Similar Items: Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?
- MRI and 18F-fluorothymidine PET-MR for the early evaluation of renal and bone marrow effects in 177Lu-DOTATATE therapy
- Patient-reported symptom and urgent healthcare use in neuroendocrine tumors
- Mesenteric paraganglioma mimicking nodal metastasis of an occult small intestinal neuroendocrine tumor
- Long-term outcomes in medullary thyroid cancer patients treated with [Lu]Lu-DOTAGA.FAPi dimer therapy
- Robust response to pembrolizumab in temozolomide-associated hypermutated and microsatellite instability-high functional pancreatic neuroendocrine tumor
- Primary tumor size as a prognostic factor in duodenal neuroendocrine neoplasms ≤20 mm: a population-based SEER analysis